Skip to Content
Merck
  • dCas9-based gene editing for cleavage-free genomic knock-in of long sequences.

dCas9-based gene editing for cleavage-free genomic knock-in of long sequences.

Nature cell biology (2022-02-12)
Chengkun Wang, Yuanhao Qu, Jason K W Cheng, Nicholas W Hughes, Qianhe Zhang, Mengdi Wang, Le Cong
ABSTRACT

Gene editing is a powerful tool for genome and cell engineering. Exemplified by CRISPR-Cas, gene editing could cause DNA damage and trigger DNA repair processes that are often error-prone. Such unwanted mutations and safety concerns can be exacerbated when altering long sequences. Here we couple microbial single-strand annealing proteins (SSAPs) with catalytically inactive dCas9 for gene editing. This cleavage-free gene editor, dCas9-SSAP, promotes the knock-in of long sequences in mammalian cells. The dCas9-SSAP editor has low on-target errors and minimal off-target effects, showing higher accuracy than canonical Cas9 methods. It is effective for inserting kilobase-scale sequences, with an efficiency of up to approximately 20% and robust performance across donor designs and cell types, including human stem cells. We show that dCas9-SSAP is less sensitive to inhibition of DNA repair enzymes than Cas9 references. We further performed truncation and aptamer engineering to minimize its size to fit into a single adeno-associated-virus vector for future application. Together, this tool opens opportunities towards safer long-sequence genome engineering.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
RAD51 Inhibitor B02, ≥98% (HPLC)